Atopic Dermatitis in Children: Addressing Misperceptions and Improving Care

0.75 CME
45 MINS
$0 FEE
SAVE

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from Pfizer Inc.


Activity Description

Many patients with atopic dermatitis (AD) are subjected to suboptimal disease management and high health care costs. In addition, the burden of this condition on patient and caregiver quality of life is often underappreciated. Appropriate diagnosis and assessment of mild-to-moderate AD can facilitate management of patients in the primary care setting, avoiding unnecessary specialist care. Best practices require awareness of disease impact as well as knowledge regarding steroid-sparing topical therapies and emerging oral options for AD that respond inadequately to topical agents alone. In this live satellite symposium, experts will provide education on the diagnosis, assessment, and treatment of patients with AD. This activity will facilitate primary care management of patients with mild-to-moderate AD while providing insight on new therapeutic options so that practice patterns align with current evidence-based care.


Target Audience

The intended audience for this activity is pediatricians, family practitioners, and other health care professionals involved in the management of patients with atopic dermatitis.


Learning Objective(s)

Upon successful completion of this activity, participants should be better able to:

  • Utilize appropriate diagnosis and assessment tools for the diagnosis of patients with AD and refer to a specialist as warranted.
  • Apply new steroid-sparing options to treat patients with mild-to-moderate AD.
  • Assess the latest evidence regarding emerging oral options to manage patients with AD who have not benefited from topical options alone.

Moderator

Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
University of California, San Diego School of Medicine
Rady Children’s Hospital San Diego
San Diego, CA


Faculty

Vikash S. Oza, MD
Assistant Professor of Dermatology and Pediatrics
Director of Pediatric Dermatology
NYU School of Medicine
New York, NY


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, February 25, 2020, through February 24, 2021.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for the questions. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Moderator and Faculty report the following relationship(s)

Lawrence F. Eichenfield, MD
No relevant financial relationships to disclose.

Dr. Vikash S. Oza MD
Consulting Fee: Cutanea Life Sciences, Regeneron-Sanofi
Contracted Research: Pfizer

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com